Back to search

Immunomodulators and delivery systems for vaccination by mucosal routes

Data up to Jan 2025

Published2001
Citations149
References107

Total Citations Per Year

Abstract

References (107)

Immunobiology of Dendritic Cells

2000 • 6,653 citations

A Toll-like receptor recognizes bacterial DNA

2000 • 6,348 citations

The expanding universe of T-cell subsets: Th1, Th2 and more

1996 • 3,710 citations

Innate Immunity: The Virtues of a Nonclonal System of Recognition

1997 • 2,397 citations

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors

2000 • 2,076 citations

Genetic immunization is a simple method for eliciting an immune response

1992 • 1,505 citations

DNA Vaccines: Immunology, Application, and Optimization

2000 • 1,212 citations

Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation

1998 • 1,190 citations

Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

1999 • 1,100 citations

Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

1996 • 1,078 citations

Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors

2000 • 754 citations

Effect of chitosan on epithelial permeability and structure

1999 • 556 citations

Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans

2000 • 498 citations

The innate immune response of the respiratory epithelium

2000 • 420 citations

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

1995 • 392 citations

Overview of interleukin-18: more than an interferon-γ inducing factor

1998 • 371 citations

Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

2000 • 365 citations

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1995 • 353 citations

Efficacy of a food plant-based oral cholera toxin B subunit vaccine

1998 • 351 citations

T cell co-stimulatory molecules other than CD28

1999 • 349 citations

A Filarial Nematode-Secreted Product Signals Dendritic Cells to Acquire a Phenotype That Drives Development of Th2 Cells

2000 • 335 citations

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

1994 • 317 citations

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

1999 • 307 citations

The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activity

1992 • 286 citations

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1999 • 283 citations

Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.

1997 • 278 citations

Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity

1998 • 264 citations

Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS

2000 • 249 citations

Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

1990 • 238 citations

Mucosal immunity and tolerance: relevance to vaccine development

1999 • 237 citations

Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.

1997 • 220 citations

Cholera Toxin Suppresses Interleukin (IL)-12 Production and IL-12 Receptor β1 and β2 Chain Expression

1999 • 213 citations

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1999 • 212 citations

Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.

1990 • 188 citations

Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile Enterotoxin

1996 • 173 citations

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant

1998 • 172 citations

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells

1995 • 168 citations

Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7- 1, B7-2 and CD28

1998 • 164 citations

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

2000 • 160 citations

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

2000 • 154 citations

Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo

1998 • 142 citations

Phase 1 Evaluation of Intranasal Virosomal Influenza Vaccine with and withoutEscherichia coliHeat-Labile Toxin in Adult Volunteers

1999 • 136 citations

Intranasal Immunization with Plasmid DNA-Lipid Complexes Elicits Mucosal Immunity in the Female Genital and Rectal Tracts

1999 • 134 citations

Single-administration vaccines: controlled-release technology to mimic repeated immunizations

1999 • 133 citations

Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages

1997 • 132 citations

Vaccine-Containing Biodegradable Microspheres Specifically Enter the Gut-Associated Lymphoid Tissue Following Oral Administration and Induce a Disseminated Mucosal Immune Response

1989 • 132 citations

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

2000 • 130 citations

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

2001 • 128 citations

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases

2000 • 126 citations

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli

2000 • 123 citations

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

1999 • 122 citations

Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

1995 • 121 citations

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

1994 • 119 citations

Nasopharyngeal-Associated Lymphoreticular Tissue (NALT) Immunity: Fimbriae-Specific Th1 and Th2 Cell-Regulated IgA Responses for the Inhibition of Bacterial Attachment to Epithelial Cells and Subsequent Inflammatory Cytokine Production

1999 • 119 citations

Mucosal DNA Vaccine Immunization Against Measles with a Highly AttenuatedShigella flexneriVector

1999 • 117 citations

Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein

1998 • 111 citations

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.

1997 • 109 citations

Adjuvant Activity of Monophosphoryl Lipid A for Nasal and Oral Immunization with Soluble or Liposome-Associated Antigen

2000 • 105 citations

A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins

1995 • 100 citations

Characterization of binding and TNF-α-inducing ability of chitosans on monocytes: the involvement of CD14

1994 • 99 citations

Mutants of Escherichia coli Heat-Labile Toxin Act as Effective Mucosal Adjuvants for Nasal Delivery of an Acellular Pertussis Vaccine: Differential Effects of the Nontoxic AB Complex and Enzyme Activity on Th1 and Th2 Cells

1999 • 98 citations

Oral DNA Vaccination Promotes Mucosal and Systemic Immune Responses to HIV Envelope Glycoprotein

2000 • 92 citations

Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity

2000 • 91 citations

Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.

1993 • 90 citations

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

1999 • 89 citations

Immune-Stimulating Complexes Induce an IL-12-Dependent Cascade of Innate Immune Responses

1999 • 85 citations

Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System

1998 • 82 citations

Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA

1999 • 81 citations

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1998 • 80 citations

Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity

1999 • 78 citations

Genetically Detoxified Mutants of Heat-Labile Toxin from Escherichia coli Are Able To Act as Oral Adjuvants

1999 • 78 citations

Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin.

1997 • 72 citations

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

2000 • 69 citations

A review of oral vaccination with transgenic vegetables

1999 • 66 citations

A Controlled Clinical Study of the Effect of Nasal Immunization with aStreptococcus mutansAntigen Alone or Incorporated into Liposomes on Induction of Immune Responses

1999 • 65 citations

Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines with Nontoxic Mutants ofEscherichia coliHeat-Labile Enterotoxins as Adjuvants Protects Mice against Invasive Pneumococcal Infections

1999 • 64 citations

Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.

1996 • 64 citations

Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited

1993 • 63 citations

Stimulation of non-specific host resistance against Sendai virus and Escherichia coli infections by chitin derivatives in mice

1987 • 62 citations

Recombinant live Salmonella spp. for human vaccination against heterologous pathogens

2000 • 61 citations

Use of CpG DNA for Enhancing Specific Immune Responses

2000 • 57 citations

Oral vaccination with immune stimulating complexes

1999 • 56 citations

Genetic Immunization with Lung-Targeting Macroaggregated Polyethyleneimine-Albumin Conjugates Elicits Combined Systemic and Mucosal Immune Responses

2000 • 56 citations

Distribution Fate and Mechanism of Immune Modulation Following Mucosal Delivery of Plasmid DNA Encoding IL-10

1999 • 54 citations

Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen

1998 • 53 citations

Recombinant liveSalmonellaspp. for human vaccination against heterologous pathogens

2000 • 52 citations

Intranasal Administration of aSchistosoma mansoniGlutathioneS-Transferase-Cholera Toxoid Conjugate Vaccine Evokes Antiparasitic and Antipathological Immunity in Mice

1999 • 51 citations

Application of Liposomes for Development of Oral Vaccines: Study of In Vitro Stability of Liposomes and Antibody Response to Antigen Associated with Liposomes after Oral Immunization.

1997 • 50 citations

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

1999 • 48 citations

Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin

1999 • 47 citations

Targeted Salivary Gland Immunization with Plasmid DNA Elicits Specific Salivary Immunoglobulin A and G Antibodies and Serum Immunoglobulin G Antibodies in Mice

1999 • 46 citations

Intranasal immunization with polymer‐grafted microparticles activates the nasal‐associated lymphoid tissue and draining lymph nodes

1998 • 46 citations

Mutational analysis of the role of ADP-ribosylation activity and GM1 -binding activity in the adjuvant properties of theEscherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

1998 • 46 citations

Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans.

1985 • 46 citations

Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers

1994 • 44 citations

In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae

1999 • 41 citations

Immune stimulating complexes as mucosal vaccines

1998 • 40 citations

Protective Immunity of Microsphere-Based Mucosal Vaccines against Lethal Intranasal Challenge withStreptococcus pneumoniae

1999 • 38 citations

Glycosphingolipids as Novel Targets for T-Cell Suppression by the B Subunit of Recombinant Heat-Labile Enterotoxin

1998 • 37 citations

Systemic and Mucosal Immunity Is Elicited after Both Intramuscular and Intravaginal Delivery of Human Immunodeficiency Virus Type 1 DNA Plasmid Vaccines to Pregnant Chimpanzees

1999 • 31 citations

Long-Term Immunological Memory Induced by Recombinant Oral Salmonella Vaccine Vectors

2000 • 31 citations

DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria

1999 • 31 citations

Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response

1996 • 30 citations

DNA-Plasmids of HIV-1 Induce Systemic and Mucosal Immune Responses

1999 • 28 citations

Induction of Mucosal Immunity against Herpes Simplex Virus Type 1 in the Mouse Protects against Ocular Infection and Establishment of Latency

1998 • 24 citations

Mucosal immune responses associated with polynucleotide vaccination.

1997 • 22 citations

Detection of precursor Th cells in mesenteric lymph nodes after oral immunization with protein antigen and cholera toxin

1997 • 17 citations

Cited By (0)

Loading...
Immunomodulators and delivery systems for vaccination by mucosal routes (2001) – Trends in biotechnology | Metascience Observatory Explorer